Canagliflozin disrupts T cell activation
Nat Rev Nephrol
.
2023 Aug;19(8):478.
doi: 10.1038/s41581-023-00739-4.
Author
Monica Wang
1
Affiliation
1
Nature Reviews Nephrology, . nrneph@nature.com.
PMID:
37369855
DOI:
10.1038/s41581-023-00739-4
No abstract available
Publication types
Comment
MeSH terms
Canagliflozin* / pharmacology
Canagliflozin* / therapeutic use
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents
T-Lymphocytes
Substances
Canagliflozin
Hypoglycemic Agents